Brief: Immunovant Reports Financial Results For The Quarter Ended Sept 30

Immunovant

04/11/2022 11:10

Nov 4 (Reuters) - Immunovant Inc  IMVT.O :
    * IMMUNOVANT REPORTS FINANCIAL RESULTS AND RECENT BUSINESS
UPDATES
FOR THE QUARTER ENDED SEPTEMBER 30, 2022
    * QUARTERLY LOSS PER SHARE $0.41
    * PRO FORMA CASH BALANCE OF $476 MILLION EXPECTED TO EXTEND
CASH
RUNWAY INTO SECOND HALF OF CALENDAR YEAR 2025
    * Q2 EARNINGS PER SHARE VIEW $-0.39 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX5pC4Kg 
Further company coverage:  IMVT.O 
 ((Reuters.Briefs@thomsonreuters.com;))